Back to search results

Improving Palliative Care for Advanced Cancer Patients in Underserved Regions

This study is looking at how a program called Project ECHO (Extension for Community Healthcare Outcomes) can improve the quality of palliative care for people with advanced cancer and their caregivers in underserved areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia. Project ECHO helps healthcare providers learn to give better care where people live. The study will measure changes in patients' quality of life over 12 months. You might be able to join if you are 18 or older, have advanced cancer, are receiving treatment at a participating clinic, are expected to live at least one year, and can read and understand English. The study is currently recruiting 312 participants, but its exact status is unclear.

Study design
This is an interventional study involving 312 participants. It is not specified if it is randomized or blinded.
What's involved
You would participate in Project ECHO clinics, in-country workshops, and professional oncology education programs. Your medical charts would be reviewed, and you would complete questionnaires.
Compensation
Not stated in the trial record.
Follow-up
Your quality of life will be measured at the beginning of the study and then up to 12 months later.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04984551

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

Recruiting
PHASE2All AgesInterventionalSupportive care
M.D. Anderson Cancer Center
~312 participants
Updated 2026-09-14 on ClinicalTrials.gov
What's tested:Extension of Community Health (ECHO) Telementoring ClinicIn-Country WorkshopsProfessional Oncology Educations ProgramsMedical Chart ReviewQuestionnaire Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in patients' quality of life
Measured over Baseline up to 12 months

Conditions

Advanced Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm

Explore related trials

Hematologic NeoplasmSolid Neoplasm

NCT04984551

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • M D Anderson Cancer Center

    Houston, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Sriram Yennu · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

Sriram Yennu
[email protected]
713-792-6085
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

PATIENT: Scheduled to receive treatment at participating primary care practice for advanced cancer
PATIENT: 18 years or older
PATIENT: Willing to be accessible to the research team for follow-up by telephone or in person
PATIENT: Prognosis of at least 1 year as ascertained by the treating physician
PATIENT: Able to read and understand English as assessed by the treating physician
CAREGIVER: Identified or self-identified as primary caregiver of the patient
CAREGIVER: Willing to be accessible to the research team for follow-up by telephone or in person
CAREGIVER: 18 years or older
CAREGIVER: Able to read and understand English as assessed by the treating physician
ECHO PARTICIPANT: Participant must be a health care provider interested to participate in the study for 2 years and understand the protocol and provide consent
ECHO PARTICIPANT: Able to read and understand English as assessed by principal investigator (PI)

Exclusion

Unable to understand and sign consent

What this trial measures

  • Change in patients' quality of lifeBaseline up to 12 months

    Measured by Functional Assessment of Cancer Illness Therapy FACT-General (FACT-G). A 27-item compilation of general questions divided into four primary domains: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, and Functional Well-Being. Each question is assessed using a Likert scale ranging from 0 to 4. The FACT-G total score is the sum of the domain scores..